» Articles » PMID: 20032403

Catalase Protects Tumor Cells from Apoptosis Induction by Intercellular ROS Signaling

Overview
Journal Anticancer Res
Specialty Oncology
Date 2009 Dec 25
PMID 20032403
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Transformed cells are subject to intercellular induction of apoptosis by neighbouring nontransformed cells and to autocrine apoptotic self-destruction. Both processes depend on extracellular superoxide anion generation by the transformed cells and on the release of peroxidase from both nontransformed and transformed cells. This concerted action results in HOCl synthesis, HOCl-superoxide anion interaction and generation of apoptosis-inducing hydroxyl radicals. In contrast to transformed cells, ex vivo tumor cells are resistant against intercellular induction of apoptosis and autocrine apoptotic self-destruction. Resistance of tumor cells against intercellular ROS signaling depends on interference through catalase expression on the membrane. Intercellular ROS signaling of tumor cells can be restored when i) exogenous HOCl is added; ii) exogenous hydrogen peroxide is supplied, or iii) catalase is inhibited. These findings define the biochemical basis for specific apoptosis induction in tumor cells through re-establishment of intercellular ROS signaling, a potential novel approach in tumor prevention and therapy.

Citing Articles

Review of cancer cell volatile organic compounds: their metabolism and evolution.

Furuhashi T, Toda K, Weckwerth W Front Mol Biosci. 2025; 11():1499104.

PMID: 39840075 PMC: 11747368. DOI: 10.3389/fmolb.2024.1499104.


Comparative Study of the Potential Cell-Penetrating Peptide ∆M4 on Apoptosis Cell Signaling in A375 and A431 Cancer Cell Lines.

Fandino-Devia E, Brankiewicz A, Santa-Gonzalez G, Guevara-Lora I, Manrique-Moreno M Pharmaceutics. 2024; 16(6).

PMID: 38931896 PMC: 11207241. DOI: 10.3390/pharmaceutics16060775.


Nanomaterials-Induced Redox Imbalance: Challenged and Opportunities for Nanomaterials in Cancer Therapy.

Wu X, Zhou Z, Li K, Liu S Adv Sci (Weinh). 2024; 11(16):e2308632.

PMID: 38380505 PMC: 11040387. DOI: 10.1002/advs.202308632.


Cellular Mechanisms of Singlet Oxygen in Photodynamic Therapy.

Przygoda M, Bartusik-Aebisher D, Dynarowicz K, Cieslar G, Kawczyk-Krupka A, Aebisher D Int J Mol Sci. 2023; 24(23).

PMID: 38069213 PMC: 10706571. DOI: 10.3390/ijms242316890.


Targeting proteasomal deubiquitinases USP14 and UCHL5 with b-AP15 reduces 5-fluorouracil resistance in colorectal cancer cells.

Ding W, Wang J, Wu J, Liu A, Jiang L, Zhang H Acta Pharmacol Sin. 2023; 44(12):2537-2548.

PMID: 37528233 PMC: 10692219. DOI: 10.1038/s41401-023-01136-0.